For example, in a preclinical study, we found that lovastatin strongly synergized with IG 2 to suppress the growth of A549 cells, a non-small cell lung carcinoma cell line with mutated K-Ras as a driver (see Supplementary Material Figure S12). The gene discussed is KRAS; the disease is small cell lung carcinoma.